Skip to content

Biora Therapeutics, Inc.: filings

Every Biora Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 18 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-11-14fiscal Q3 2024451310000950170-24-127060
10-Q2024-08-12fiscal Q2 2024451270000950170-24-095491
10-Q2024-05-15fiscal Q1 202443890000950170-24-060530
10-K2024-04-01fiscal FY 202347960000950170-24-039423
10-Q2023-11-13fiscal Q3 2023451320000950170-23-063022
10-Q2023-08-14fiscal Q2 2023451280000950170-23-042476
10-Q2023-05-15fiscal Q1 202343900000950170-23-022259
10-K2023-03-30fiscal FY 2022501340000950170-23-010973
10-Q2022-11-14fiscal Q3 2022491440000950170-22-025103
10-Q2022-08-15fiscal Q2 2022451230000950170-22-017429
10-Q2022-05-10fiscal Q1 202242860000950170-22-009028
10-K2022-03-28fiscal FY 2021461190000950170-22-004791
10-Q2021-11-10fiscal Q3 2021431250000950170-21-004127
10-Q2021-08-12fiscal Q2 2021431150000950170-21-001377
10-Q2021-05-13fiscal Q1 202144900001564590-21-027610
10-K2021-03-18fiscal FY 2020471250001564590-21-014182
10-Q2020-11-09fiscal Q3 2020441210001564590-20-052554
10-Q2020-08-14fiscal Q2 2020441170001564590-20-040288

Inspect the source

Entity
Biora Therapeutics, Inc. / CIK 0001580063
Captured
2026-09-21T17:20:55.766Z
SEC response SHA-256
fec25fcdb7fb06d85feffd9ee17ee9160f293afb10e93fa3d30b4aea9eeb0ba2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001580063.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))